Ligand validation:9PDA

PG5: 1-METHOXY-2-[2-(2-METHOXY-ETHOXY]-ETHANE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
9PDA_PG5_B_305	14%	71%	0.222	0.776	0.42	0.7	-	-	3	0	100%	0.61
9PDA_PG5_A_305	13%	92%	0.173	0.711	0.33	0.2	-	-	2	0	100%	0.65
9PDA_PG5_A_302	10%	91%	0.178	0.683	0.3	0.28	-	-	2	0	100%	0.74
9PDA_PG5_C_305	9%	92%	0.178	0.666	0.31	0.2	-	-	1	0	100%	0.78
9PDA_PG5_B_311	8%	91%	0.163	0.641	0.31	0.25	-	-	4	0	100%	0.6
9PDA_PG5_A_304	8%	92%	0.2	0.674	0.28	0.27	-	-	2	0	100%	0.62
9PDA_PG5_D_312	6%	68%	0.271	0.71	0.35	0.87	-	-	4	0	100%	0.61
9PDA_PG5_D_304	5%	93%	0.163	0.562	0.3	0.17	-	-	1	0	100%	0.71
9PDA_PG5_B_327	5%	94%	0.191	0.584	0.3	0.16	-	-	0	0	100%	0.65
9PDA_PG5_C_306	4%	90%	0.238	0.628	0.32	0.3	-	-	3	0	100%	0.57
9PDA_PG5_D_303	4%	93%	0.257	0.644	0.29	0.18	-	-	4	0	100%	0.46
9PDA_PG5_B_307	4%	92%	0.21	0.587	0.31	0.2	-	-	1	0	100%	0.55
9PCT_PG5_A_320	17%	87%	0.18	0.755	0.41	0.3	-	-	0	0	100%	0.74
3MR0_PG5_B_143	100%	88%	0.02	0.995	0.43	0.25	-	-	2	0	100%	1
4IQF_PG5_A_401	86%	43%	0.072	0.971	0.67	1.52	-	-	0	0	83%	1
3RIH_PG5_A_273	72%	83%	0.116	0.939	0.46	0.33	-	-	0	0	100%	1
3D01_PG5_J_166	69%	76%	0.106	0.921	0.47	0.49	-	-	1	0	100%	1
5AII_PG5_A_1130	60%	75%	0.091	0.876	0.58	0.39	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.